2.35
Spero Therapeutics Inc Aktie (SPRO) Neueste Nachrichten
What drives Spero Therapeutics Inc. stock priceConsistently outstanding ROI - jammulinksnews.com
What analysts say about Spero Therapeutics Inc. stockOutstanding capital appreciation - jammulinksnews.com
Spero Therapeutics Inc. Stock Analysis and ForecastConsistently superior profits - jammulinksnews.com
Is Spero Therapeutics Inc. a good long term investmentFree Bull & Bear Market Updates - Autocar Professional
Will Spero Therapeutics Inc. stock benefit from AI tech trendsTrend Based Entry Alerts - Newser
When is the best time to buy Spero Therapeutics Inc. stockFree Real-Time Trading Opportunities - Newser
Insufficient Growth At Spero Therapeutics, Inc. (NASDAQ:SPRO) Hampers Share Price - simplywall.st
What makes Spero Therapeutics Inc. stock price move sharplyMarket Timing Advice - Newser
Why Spero Therapeutics Inc. stock attracts strong analyst attentionTop Momentum Stock Pick - Newser
How Spero Therapeutics Inc. stock performs during market volatilityBreakout Level Watch - Newser
Spero Therapeutics (NASDAQ:SPRO) Stock Passes Above Fifty Day Moving Average – What’s Next? - Defense World
While institutions own 20% of Spero Therapeutics, Inc. (NASDAQ:SPRO), retail investors are its largest shareholders with 54% ownership - Yahoo
Is Spero Therapeutics, Inc. overvalued or undervalued? - MarketsMojo
Complicated Urinary Tract Infection Pipeline Appears Robust With 12+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - The Globe and Mail
SPRO’s Stock Market Pendulum: Swinging Between Gains and Losses - investchronicle.com
Spero TherapeuticsAdditional Upside Potential Following Positive Phase 3 Results (SPRO) - Seeking Alpha
Squarepoint Ops LLC Buys Shares of 55,051 Spero Therapeutics, Inc. (NASDAQ:SPRO) - Defense World
Spero Therapeutics COO Timothy Keutzer sells shares for $44,097 - MSN
Jane Street Group LLC Takes Position in Spero Therapeutics, Inc. (NASDAQ:SPRO) - Defense World
Spero Therapeutics Inc (SPRO) Is A Good Stock To Invest In - Stocksregister
Spero Therapeutics, Inc. (NASDAQ:SPRO) Stake Boosted by Mackenzie Financial Corp - Defense World
GSK, Spero Therapeutics Stop Antibiotic Trial For Complicated Urinary Tract Infections Early After Positive Results, Retail’s Thrilled - MSN
Northern Trust Corp Sells 25,050 Shares of Spero Therapeutics, Inc. (NASDAQ:SPRO) - Defense World
Why Spero Therapeutics, Inc. (SPRO) Surged Last Week - Insider Monkey
Spero Therapeutics stock hits 52-week high at $2.53 By Investing.com - Investing.com South Africa
Complicated Urinary Tract Infection Oral Antibiotic Approaches Approval - Vax-Before-Travel
Spero Therapeutics stock hits 52-week high at $2.53 - Investing.com India
Spero Therapeutics Jumps as Oral Carbapenem Hits Phase 3 Milestone - MSN
SPRO Stock Soars 245% on GSK-Partnered UTI Drug Meeting Study Goal - MSN
Spero Therapeutics Stock (SPRO) Rockets 225% on Clinical Trial Data - The Globe and Mail
Spero Therapeutics And 2 Other Promising Penny Stocks To Watch - Yahoo Finance
Spero Therapeutics rockets on positive Phase III study for tebipenem HBr - The Pharma Letter
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):